MedPath

Diclofenac

Diclofenac Sodium Ophthalmic Solution 0_1

Approved
Approval ID

5372866a-dab3-45c8-8c2a-755ca36c1791

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 28, 2022

Manufacturers
FDA

Altaire Pharmaceuticals Inc.

DUNS: 786790378

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diclofenac Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59390-149
Application NumberANDA203383
Product Classification
M
Marketing Category
C73584
G
Generic Name
Diclofenac Sodium
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateOctober 31, 2022
FDA Product Classification

INGREDIENTS (7)

POLYOXYL 35 CASTOR OILInactive
Code: 6D4M1DAL6O
Classification: IACT
DICLOFENAC SODIUMActive
Quantity: 1 mg in 1 mL
Code: QTG126297Q
Classification: ACTIB
BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
TROMETHAMINEInactive
Code: 023C2WHX2V
Classification: IACT
SORBIC ACIDInactive
Code: X045WJ989B
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diclofenac - FDA Drug Approval Details